4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine

C18H29N3O2 — CID 135119659

IUPAC4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine
SMILESCC(CN1CCC(OCc2ccccn2)CC1)N1CCOCC1
InChIInChI=1S/C18H29N3O2/c1-16(21-10-12-22-13-11-21)14-20-8-5-18(6-9-20)23-15-17-4-2-3-7-19-17/h2-4,7,16,18H,5-6,8-15H2,1H3
InChIKeyVIYXFWITXBZCRP-UHFFFAOYSA-N
MW319.45 g/mol
LogP1.78
Rot. Bonds6

About 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine

4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine (PubChem CID 135119659) has the molecular formula C18H29N3O2 and a molecular weight of 319.45 g/mol. Its IUPAC name is 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine.

Molecular Properties

Compound Name4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine
PubChem CID135119659
Molecular FormulaC18H29N3O2
Molecular Weight319.45 g/mol
Exact Mass319.23
IUPAC Name4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine
SMILESCC(CN1CCC(OCc2ccccn2)CC1)N1CCOCC1
InChIInChI=1S/C18H29N3O2/c1-16(21-10-12-22-13-11-21)14-20-8-5-18(6-9-20)23-15-17-4-2-3-7-19-17/h2-4,7,16,18H,5-6,8-15H2,1H3
InChIKeyVIYXFWITXBZCRP-UHFFFAOYSA-N
XLogP1.78
TPSA37.83 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500319.45
LogP ≤ 51.78
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(1-propan-2-ylpiperidin-4-yl)oxymethyl]pyridine
CID 134434529
2-[[1-(1,4-dioxan-2-ylmethyl)piperidin-4-yl]oxymethyl]pyridine
CID 91830622
2-[[1-[(2S)-3-(1,3-benzodioxol-5-yl)-2-methylpropyl]piperidin-4-yl]oxymethyl]pyridine
CID 99953756
5-(methoxymethyl)-3-[[4-(pyridin-2-ylmethoxy)piperidin-1-yl]methyl]-1,2,4-oxadiazole
CID 135106283
2-[[1-(2-methylpropyl)piperidin-4-yl]methyl]pyridine
CID 174571259
3-[2-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]ethyl]-1H-imidazol-2-one
CID 135104344
5-methyl-2-(5-methylthiophen-2-yl)-4-[[4-(pyridin-2-ylmethoxy)piperidin-1-yl]methyl]-1,3-oxazole
CID 42532058
2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]ethanone
CID 118775788
N-[[(2R)-oxolan-2-yl]methyl]-4-(pyridin-2-ylmethoxy)piperidine-1-carboxamide
CID 121496359
(E,2S)-2-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]hept-3-enoic acid
CID 97193866
2-(oxan-4-yl)-8-(pyridin-2-ylmethoxy)-5-oxa-2-azaspiro[3.5]nonane
CID 131648833
5-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]-6-pyrrolidin-1-yl-[1,2,5]oxadiazolo[3,4-b]pyrazine
CID 42101463

Frequently Asked Questions

What is the IUPAC name of 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine?
The IUPAC name of 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine (CID 135119659) is 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine.
What is the SMILES notation for 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine?
The canonical SMILES for 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine is CC(CN1CCC(OCc2ccccn2)CC1)N1CCOCC1.
What is the InChIKey of 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine?
The InChIKey is VIYXFWITXBZCRP-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H29N3O2/c1-16(21-10-12-22-13-11-21)14-20-8-5-18(6-9-20)23-15-17-4-2-3-7-19-17/h2-4,7,16,18H,5-6,8-15H2,1H3.
What are the key properties of 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine?
4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine has a molecular weight of 319.45 g/mol, XLogP of 1.78, 6 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-[4-(pyridin-2-ylmethoxy)piperidin-1-yl]propan-2-yl]morpholine is sourced from PubChem (CID 135119659), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).